Breast Cancer
FTH-PIK-101: Open-Label Umbrella Study to Evaluate Safety and Efficacy of Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients with HR+/HER2- Advanced or Metastatic Breast Cancer
- Details
ClinicalTrials.gov ID:
NCT07558733
Diagnosis Type:
NA
USOR Number:
- Address
,
P: